EU Makes ISO Format Mandatory For Side-Effect Reporting From June 2022

New Standard Offers Improved Quality Of Data Collected

Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.

Side effects
Mandatory Use Of ISO ICSR standard will improve patient safety • Source: Shutterstock

The European Medicines Agency is making it mandatory for drug companies to use a new consistent international standard – the International Organization for Standardization’s individual case safety report (ICSR) format – for reporting individual cases of suspected side-effects in patients as of 30 June 2022.

The use of the ISO ICSR format will become mandatory for all reporting to EudraVigilance, the European database of suspected...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography